ABSA International
ABSA International

Resources with keywords: covid-19



What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring (NEW 4/30, Website, Publication)
JAMA
17 April 2026

Rubin R
By Feb. 2026, the cicada variant has been been identified in at least 23 countries.

Early Detection and Surveillance of the SARS-CoV-2 Variant BA.3.2 — Worldwide, November 2024–February 2026 (NEW 6/1, Website, Publication)
CDC / MMWR
19 March 2026

Shakya M, Ma KC, Hughes LJ, et al.
In the United States, BA.3.2 (“cicada variant”) was detected in nasal swabs from four travelers, three airplane wastewater samples, clinical samples from five patients, and 132 wastewater samples from 25 U.S. states.

Global Virus Network Monitors SARS-CoV-2 Variant BA.3.2 (“Cicada”), Emphasizes No Cause for Alarm (NEW 6/1, Website)
CDC

GVN assessment (3 Apr 2026) concludes BA.3.2 shows antibody escape but no evidence of increased severity or aerosol-generating transmissibility beyond known Omicron characteristics. Standard clinical laboratory biosafety (BSL-2) remains appropriate for routine SARS-CoV-2 specimen processing. Facilities should continue wastewater surveillance as an early-warning tool for variant emergence that could affect HCW exposure levels.

ACIP Recommends COVID-19 Immunization Based on Individual Decision-making (NEW 10/14, Regulatory)
U.S. Health and Human Services (HHS)

ACIP’s recommendation applies to all individuals six months and older. It includes an emphasis that the risk-benefit of vaccination in individuals under age 65 is most favorable for those who are at an increased risk for severe COVID-19 and lowest for individuals who are not at an increased risk, according to the CDC list of COVID-19 risk factors.

Coronavirus (COVID-19) | CBER-Regulated Biologics (NEW 10/14, Regulatory)
FDA
Bat Cave Footage Offers Clues to How Viruses Leap Between Species
New York Times
16 June 2025

Ham A.
Video from a national park in Uganda depicted a parade of predatory species feeding on and dispersing fruit bats that are known natural reservoirs of infectious diseases.

Laboratory Biosafety Guidelines for working with SARS-CoV-2 (NEW 4/20, Website, Regulatory)
CDC

Emphasizes this guidance is specific to SARS-CoV-2 and does not apply to other Corona Viruses

The hospital and mortality burden of COVID-19 compared with influenza in Denmark: a national observational cohort study, 2022–24 (NEW 2/10, Website, Publication)
The Lancet - Infectious Diseases
29 January 2025

P Bager, et al.
An observational study comparing the severity of COVID-19 and influenza among nearly 6 million Denmark residents finds a higher rate of hospitalizations and deaths in those infected with SARS-CoV-2—mainly among unvaccinated people, those with chronic conditions, and males—from 2022 to 2024.

Wastewater Monitoring Dashboard for Canada (NEW 1/11, Website, Regulatory)
Governement of Canada- National Collaboration Centre for Infectious Diseases

This dashboard provides data about COVID-19, flu, RSV and mpox virus levels in wastewater.

CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who are Moderately or Severely Immunocompromised (NEW 11/11, Website, News)
CDC Newsroom
23 October 2024

CDC endorsing that people 65 years and older and those who are moderately or severely immunocompromised receive a second dose of 2024-2025 COVID-19 vaccine six months after their first dose.

Go to Top